Sun Pharma Advanced Research Company Ltd Quarterly Results

Gross Sales

7.86

9.64

27.19

14.91

12.86

Excise Duty

0

0

0

0

0

Net Sales

7.86

9.64

27.19

14.91

12.86

Other Operating Income

0

0

0

0

0

Other Income

0.01

9.14

0

0.19

0.04

Total Income

7.87

18.78

27.19

15.1

12.9

Total Expenditure

73.58

61.72

80.37

88.6

115.77

PBIDT

-65.71

-42.94

-53.18

-73.5

-102.87

Interest

7.52

6.19

4.54

2.8

1.14

PBDT

-73.23

-49.13

-57.72

-76.3

-104.01

Depreciation

2.56

2.68

2.95

3.14

3.16

Minority Interest Before NP

0

0

0

0

0

Tax

0.06

0.06

-0.9

0.07

0.16

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-75.85

-51.87

-59.77

-79.51

-107.33

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-75.85

-51.87

-59.77

-79.51

-107.33

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-75.85

-51.87

-59.77

-79.51

-107.33

EPS (Unit Curr.)

-2.34

-1.6

-1.84

-2.45

-3.31

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

32.45

32.45

32.45

32.45

32.45

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-836

-445.43

-195.58

-492.95

-799.92

PBDTM(%)

-931.67

-509.64

-212.28

-511.73

-808.78

PATM(%)

-965.01

-538.07

-219.82

-533.26

-834.6